Source link : https://www.newshealth.biz/health-news/if-at-first-tirzepatide-doesnt-succeed-keep-trying/
NEW ORLEANS — When using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off. New post hoc data from Lilly’s SURMOUNT-1 trial of people with overweight or obesity but not diabetes suggest that the drug will almost always produce at least 5% weight loss eventually, even among slow responders. “Some obesity treatment guidelines […]
Author : News Health
Publish date : 2024-05-10 18:43:41
Copyright for syndicated content belongs to the linked Source.
Categories